Association between single nucleotide polymorphisms of DNA repair genes (BRCA1, BRCA2, and PALB2) and breast cancer incidence in a subset of Iranian population

被引:0
|
作者
Jahangiri, Sepideh [1 ]
Abdan, Zahra [1 ]
Houshmand, Massoud [2 ]
Souroush, Ali [3 ]
Aznab, Mozaffar [1 ,4 ]
机构
[1] Kermanshah Univ Med Sci, Clin Res Dev Ctr, Imam Reza Hosp, Kermanshah, Iran
[2] Natl Inst Genet & Biotechnol, Dept Med Genet, Tehran, Iran
[3] Kermanshah Univ Med Sci, Dept Med Phys, Kermanshah, Iran
[4] Kermanshah Univ Med Sci, Internal Med Dept, Med Oncol Hematol, Kermanshah, Iran
关键词
Breast cancer; BRCA1; BRCA2; PALB2; Polymorphism; TURKISH POPULATION; MUTATIONS; SUSCEPTIBILITY; RISK;
D O I
10.1186/s13053-025-00311-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundBreast cancer (BC) is the most common malignancy among Iranian females, accounting for 24.4% of all malignancies. Germ line mutations in DNA repair system-related genes are associated with an increased risk of BC. This study aims to evaluate the frequencies of single nucleotide polymorphisms (SNPs) in the BRCA1, BRCA2, and PALB2 genes in patients with BC from a subset of the Iranian population in the western part of Iran.MethodsBlood samples were collected from 335 patients with BC and 354 healthy matched volunteers. Genomic DNA was extracted using the salting-out method and, after quality control, was genotyped using the multiplex TaqMan allelic discrimination assay for three SNPs: rs80359550 (6174 delT) in the BRCA2 gene, rs180177102 in the PALB2 gene, and rs386833395 (185delAG) in the BRCA1 gene. Statistical analysis was performed to examine allele frequency, odds ratio, and relative risk (genetic association) in a retrospective case-control study.ResultsThe data showed no association between rs386833395 and BC risk in the studied population (odds ratio = 1), whereas rs80359550 and rs180177102 polymorphisms were strongly associated with BC risk in patients (odds ratio = 0.01 for both, with p-values of 0.011 and 0.021, respectively).ConclusionsOur findings suggest no significant association between the rs386833395 polymorphism and BC risk in the Iranian Kurdish population, while rs80359550 and rs180177102 polymorphisms were strongly associated with BC. However, the study has several limitations, including its retrospective design, a relatively small sample size, and the potential lack of generalizability to other ethnic groups within Iran. Future studies involving larger cohorts and more diverse populations are needed to confirm these results.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer
    Dombernowsky, Sarah Louise
    Weischer, Maren
    Freiberg, Jacob Johannes
    Bojesen, Stig Egil
    Tybjaerg-Hansen, Anne
    Nordestgaard, Borge Gronne
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (08) : 2339 - 2342
  • [42] Frequency of large rearrangements in BRCA1, BRCA2, ATM, CHEK2, and PALB2 in hereditary cancer testing
    Bissonnette, J.
    Doonanco, K.
    Xu, Z.
    Klein, R. T.
    Hruska, K. S.
    CANCER RESEARCH, 2016, 76
  • [43] Compromised BRCA1–PALB2 interaction is associated with breast cancer risk
    T K Foo
    M Tischkowitz
    S Simhadri
    T Boshari
    N Zayed
    K A Burke
    S H Berman
    P Blecua
    N Riaz
    Y Huo
    Y C Ding
    S L Neuhausen
    B Weigelt
    J S Reis-Filho
    W D Foulkes
    B Xia
    Oncogene, 2017, 36 : 4161 - 4170
  • [44] High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer
    Smirnova, T. Yu.
    Pospekhova, N. I.
    Lyubchenko, L. N.
    Tjulandin, S. A.
    Gar'kavtseva, R. F.
    Ginter, E. K.
    Karpukhin, A. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 144 (01) : 83 - 85
  • [45] High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer
    T. Yu. Smirnova
    N. I. Pospekhova
    L. N. Lyubchenko
    S. A. Tjulandin
    R. F. Gar’kavtseva
    E. K. Ginter
    A. V. Karpukhin
    Bulletin of Experimental Biology and Medicine, 2007, 144 : 83 - 85
  • [46] Analysis of BRCA1 and BRCA2 genes mutations in women with breast cancer in Georgian population
    Pirtskhelani, N.
    Kochiashvili, N.
    Kartvelishvili, K.
    Dzagnidze, G.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1912 - 1912
  • [47] Clinicopathological features of PALB2 and BRCA2 mutation carriers with breast cancer
    Aranda-Gutierrez, Alejandro
    Ferrigno, Ana S.
    Garcia Marrufo, Juan Carlos A.
    Moncada-Madrazo, Mariana
    Gomez-Picos, Analy
    Villarreal-Garza, Cynthia
    Aguilar, Dione
    CANCER RESEARCH, 2021, 81 (04)
  • [48] The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
    Cao, A-Yong
    Huang, Juan
    Hu, Zhen
    Li, Wen-Feng
    Ma, Zhong-Liang
    Tang, Li-Li
    Zhang, Bin
    Su, Feng-Xi
    Zhou, Jie
    Di, Gen-Hong
    Shen, Kun-Wei
    Wu, Jiong
    Lu, Jin-Song
    Luo, Jian-Min
    Yuan, Wen-Tao
    Shen, Zhen-Zhou
    Huang, Wei
    Shao, Zhi-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 457 - 462
  • [49] Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina
    Cerretini, Roxana
    Mercado, Graciela
    Morganstein, Josh
    Schiaffi, Jorge
    Reynoso, Monica
    Montoya, Diana
    Valdez, Rita
    Narod, Steven A.
    Akbari, Mohammad R.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (03) : 629 - 636
  • [50] The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
    A-Yong Cao
    Juan Huang
    Zhen Hu
    Wen-Feng Li
    Zhong-Liang Ma
    Li-Li Tang
    Bin Zhang
    Feng-Xi Su
    Jie Zhou
    Gen-Hong Di
    Kun-Wei Shen
    Jiong Wu
    Jin-Song Lu
    Jian-Min Luo
    Wen-Tao Yuan
    Zhen-Zhou Shen
    Wei Huang
    Zhi-Ming Shao
    Breast Cancer Research and Treatment, 2009, 114 : 457 - 462